(Q45047434)
Statements
Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus (English)
Christian Teschendorf
Kenneth H Warrington
Dietmar W Siemann
Nicholas Muzyczka
1 November 2002